Resonance Health Ltd(AU:RHT)
A$0.08+0.00 (+5.26%)
AU:RHT
Resonance Health Ltd financials statements
A$0.08
At close:+0.00 (+5.26%)
Want to see AU:RHT full AI Analyst Report?
Resonance Health Ltd (RHT) Ratios
3 Followers
Resonance Health Ltd Ratios
AU:RHT's free cash flow for Q4 2026 was AU$2.65M. For the 2026 fiscal year, AU:RHT's free cash flow was decreased by AU$-58.31K and operating cash flow was AU$2.71M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.13 | 1.28 | 1.51 | 8.63 | 10.34 |
| Quick Ratio | 1.13 | 1.28 | 1.51 | 8.63 | 10.34 |
| Cash Ratio | 0.74 | 0.57 | 1.12 | 7.27 | 8.40 |
| Solvency Ratio | 0.32 | -0.09 | 0.07 | -0.33 | -0.72 |
| Operating Cash Flow Ratio | 0.44 | 0.24 | 0.23 | -0.18 | -0.88 |
| Short-Term Operating Cash Flow Coverage | 1.04 | 3.90 | 4.34 | -1.56 | -8.93 |
| Net Current Asset Value | AU$ -169.53K | AU$ -1.88M | AU$ -66.09K | AU$ 6.51M | AU$ 7.35M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.21 | 0.18 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.34 | 0.40 | 0.34 | 0.03 | 0.03 |
| Debt-to-Capital Ratio | 0.26 | 0.29 | 0.25 | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.21 | 0.21 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.69 | 1.91 | 1.86 | 1.11 | 1.09 |
| Debt Service Coverage Ratio | 0.93 | -1.70 | 1.29 | -3.42 | -11.69 |
| Interest Coverage Ratio | 4.52 | -6.05 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.13 | 0.16 | 0.12 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.42 | -1.34 | 8.27 | 7.36 | 4.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 93.95% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | 9.72% | -14.30% | -10.23% | -28.70% | -46.29% |
| EBITDA Margin | 15.77% | -5.59% | -4.45% | -18.79% | -35.08% |
| Operating Profit Margin | 9.72% | -17.42% | -10.23% | -36.89% | -46.29% |
| Pretax Profit Margin | 6.98% | -19.86% | -7.30% | -28.70% | -40.54% |
| Net Profit Margin | 9.61% | -15.65% | 1.97% | -17.71% | -29.83% |
| Continuous Operations Profit Margin | 9.61% | -24.07% | 1.97% | -17.71% | -29.83% |
| Net Income Per EBT | 137.62% | 78.81% | -27.00% | 61.71% | 73.58% |
| EBT Per EBIT | 71.81% | 114.00% | 71.33% | 77.79% | 87.58% |
| Return on Assets (ROA) | 8.07% | -9.69% | 0.83% | -7.10% | -9.77% |
| Return on Equity (ROE) | 13.61% | -18.45% | 1.55% | -7.85% | -10.68% |
| Return on Capital Employed (ROCE) | 12.59% | -15.18% | -6.22% | -16.08% | -16.29% |
| Return on Invested Capital (ROIC) | 10.26% | -14.62% | 1.62% | -9.73% | -11.81% |
| Return on Tangible Assets | 15.94% | -15.90% | 1.62% | -9.43% | -12.95% |
| Earnings Yield | 7.27% | -9.76% | 0.63% | -4.03% | -4.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.37 | 4.26 | 3.70 | 3.85 | 2.54 |
| Payables Turnover | 1.18 | 2.41 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.81 | 7.04 | 8.46 | 6.99 | 9.79 |
| Asset Turnover | 0.84 | 0.62 | 0.42 | 0.40 | 0.33 |
| Working Capital Turnover Ratio | 13.66 | 4.85 | 1.75 | 0.62 | 0.46 |
| Cash Conversion Cycle | -253.01 | -65.82 | 98.61 | 94.80 | 143.51 |
| Days of Sales Outstanding | 57.32 | 85.76 | 98.61 | 94.80 | 143.51 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 310.33 | 151.58 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 57.32 | 85.76 | 98.61 | 94.80 | 143.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | 0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.01 | 0.00 | 0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 30.40 | 2.82 | 3.68 | -0.34 | -1.01 |
| Capital Expenditure Coverage Ratio | 30.40 | 2.82 | 3.68 | -0.34 | -1.01 |
| Operating Cash Flow Coverage Ratio | 0.76 | 0.33 | 0.38 | -0.58 | -2.66 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.11 | 0.16 | -0.04 | -0.19 |
| Free Cash Flow Yield | 13.39% | 4.54% | 3.75% | -3.23% | -5.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.75 | -10.26 | 158.93 | -24.83 | -22.61 |
| Price-to-Sales (P/S) Ratio | 1.32 | 1.60 | 3.13 | 4.40 | 6.75 |
| Price-to-Book (P/B) Ratio | 1.87 | 1.89 | 2.46 | 1.95 | 2.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.47 | 22.05 | 26.64 | -30.99 | -18.23 |
| Price-to-Operating Cash Flow Ratio | 7.22 | 14.22 | 19.40 | -123.34 | -36.24 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.01 | -1.29 | 0.78 | 0.08 |
| Enterprise Value Multiple | 7.96 | -30.04 | -62.17 | -16.04 | -14.38 |
| Enterprise Value | 19.77M | 18.58M | 23.75M | 13.28M | 19.31M |
| EV to EBITDA | 7.96 | -30.04 | -62.17 | -16.04 | -14.38 |
| EV to Sales | 1.26 | 1.68 | 2.77 | 3.02 | 5.04 |
| EV to Free Cash Flow | 7.10 | 23.07 | 23.52 | -21.25 | -13.63 |
| EV to Operating Cash Flow | 6.86 | 14.88 | 17.12 | -84.57 | -27.09 |
| Tangible Book Value Per Share | 0.00 | 0.01 | 0.00 | 0.02 | 0.02 |
| Shareholders’ Equity Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.38 | -0.21 | 1.27 | 0.38 | 0.26 |
| Revenue Per Share | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Net Income Per Share | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Tax Burden | 1.38 | 0.79 | -0.27 | 0.62 | 0.74 |
| Interest Burden | 0.72 | 1.39 | 0.71 | 1.00 | 0.88 |
| Research & Development to Revenue | 0.03 | 0.09 | 0.10 | 0.16 | 0.19 |
| SG&A to Revenue | 0.81 | 0.89 | 0.53 | 0.71 | 0.65 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.10 | 0.01 | 0.00 |
| Income Quality | 1.90 | -0.72 | 8.19 | 0.20 | 0.62 |
Currency in AUD

